Search results
Hereditary Angioedema Attacks Reduced With Donidalorsen Prophylaxis
MedPage Today· 2 days agoThe least-squares mean time-normalized HAE attack rate was 0.44 with donidalorsen given every 4...
HI-Bio reports findings from Phase II trial in kidney transplant recipients
Clinical Trials Arena via Yahoo Finance· 6 days agoThe investigator-sponsored, double-blind, placebo-controlled study aimed to evaluate the safety and...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 2 days agos Leqembi gained full approval for Alzheimer's treatment based on its ability to remove amyloid. In...
HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated...
StreetInsider· 6 days ago82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus 20% (n=2/10) who received placebo, and patients treated with felzartamab showed...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 5 days agoAfter 24 weeks, resolution of morphologic antibody-mediated rejection occurred in nine of the 11...
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 3 days agoIGNAZ is an ongoing, randomised, double-blind, placebo-controlled, multicentre, Phase IIa study to...
Plozasiran Paves RNA Interference Path to Triglyceride Reduction
MedPage Today· 5 days agoIn such individuals, known to be at increased risk of atherosclerotic cardiovascular disease...
New therapy proven effective against rejection in kidney transplantation
Medical Xpress· 5 days agoAs part of an international and multidisciplinary clinical study led by Georg Böhmig and Katharina Mayer, Clinical Division of Nephrology and Dialysis, Department of Medicine III at MedUni Vienna ...
'Your Choice Impacts Others'
Cape May County Herald· 2 days agoEditor’s Note: Cape May County ranks 15th nationwide and first in the state as a second home destination, so this summer the Herald will be periodically...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoOncocyte’s Drs. Ekke Schuetz and Julia Beck, inventors of the technology, are among the authors of the study. VitaGraft Kidney was used to monitor graft injury in a phase 2 double-blind, < ...